Patients taking semaglutide should understand which symptoms require immediate medical attention versus those that can be addressed at routine follow-up appointments
Upper Arm The upper arm is a valid injection site but slightly less convenient for self-injection
Raijmakers R, Roerink M, Keijmel S, Joosten L, Netea M, van der Meer J, et al
Expired or degraded peptide may reduce efficacy without obvious signs
Research on related incretin-based therapies has flagged possible signals: a 2021 meta-analysis of semaglutide trials drawn from SUSTAIN and PIONEER data reported an increased rate of deep vein thrombosis in pooled analyses
The Dual Glucose-dependent Insulinotropic Polypeptide and Glucagon-like Peptide-1 Receptor Agonist Tirzepatide Improves Cardiovascular Risk Biomarkers in Patients with Type 2 Diabetes: A p ost hoc Analysis